LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Accounts Payable

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A (LFMDP) currently reports a accounts payable of $22M as of March 2026. That compares with $16M in the prior-year period — up 38.1% year over year. Use the charts on this page to explore LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's accounts payable history and peer comparisons.

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's accounts payable increased from $16M to $22M — a 38.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A reported $22M in accounts payable as of March 2026. That compares with $16M in the prior-year period — up 38.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $22M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A, and consider following LFMDP for alerts when major investors trade the stock.

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A is classified in the Healthcare sector. On accounts payable, it currently shows $22M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LFMDP with unrelated industries.